| Oliver Sabot Costs and financial feasibility of malaria eliminationOliver Sabot Clinton Health Access Initiative, Boston, MA 02127, USA Lancet 376:1604-15. 2010 Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessmentAllison Tatarsky Clinton Health Access Initiative, Boston, Massachusetts, United States of America PLoS ONE 6:e23832. 2011 Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in UgandaJessica L Cohen Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA Malar J 11:83. 2012 Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of TanzaniaPrashant Yadav Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA Malar J 11:299. 2012 A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shopsJustin M Cohen Clinton Health Access Initiative, 383 Dorchester Ave, Boston MA, 02127, USA BMC Health Serv Res 10:S6. 2010 A framework for assessing the feasibility of malaria eliminationBruno Moonen Clinton Health Access Initiative, Boston, USA Malar J 9:322. 2010
| |